FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: developmental and epileptic encephalopathy 44
Open Close
General Information
Name
developmental and epileptic encephalopathy 44
FlyBase ID
FBhh0001550
Overview

This report describes developmental and epileptic encephalopathy 44, a subtype of developmental and epileptic encephalopathy that exhibits autosomal dominant inheritance. The human gene implicated is UBA5, which encodes ubiquitin like modifier activating enzyme 5, a member of the E1-like ubiquitin-activating enzyme family. There is one high-scoring fly ortholog, Dmel\Uba5, for which multiple genetic reagents, including amorphic alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis, have been generated.

UAS constructs of the human Hsap\UBA5 gene have been introduced into flies, including wild-type and variants implicated in human disease. See the 'Disease-Implicated Variants' table below. Heterologous rescue (functional complementation) has been demonstrated for the Dmel\Uba5 embryonic lethal phenotype. Variants implicated in human disease, when expressed in flies mutant for Dmel\Uba5, fell into three classes based on efficacy of rescuing the lethal phenotype, and presence of other phenotypes including decreased lifespan and bang-sensitivity in adults.

Amorphic mutations in Dmel\Uba5 are almost entirely embryonic lethal, with a few escapers surviving to the first larval instar,

[updated Dec. 2023 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: developmental and epileptic encephalopathy
Symptoms and phenotype
Specific Disease Summary: developmental and epileptic encephalopathy 44
OMIM report

[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44; DEE44](https://omim.org/entry/617132)

Human gene(s) implicated

[UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 5; UBA5](https://omim.org/entry/610552)

Symptoms and phenotype

Developmental and epileptic encephalopathy-44 (DEE44) is an autosomal recessive neurologic disorder characterized by the onset of refractory infantile spasms or myoclonus usually in the first weeks or months of life, up to about 12 months of age. Affected infants may have normal or mildly delayed development before the onset of seizures, but thereafter show developmental stagnation and severe neurologic impairment. EEG in some patients shows hypsarrhythmia, consistent with a clinical diagnosis of West syndrome. Additional features include poor feeding and poor overall growth with microcephaly, axial hypotonia with peripheral hypertonia or spasticity, abnormal movements, limited eye contact, and profoundly impaired intellectual development with absent language. Many patients require tube feeding, and some die in childhood (summary by Muona et al., 2016, pubmed: 2754567; Colin et al., 2016, pubmed:27545681). [from MIM:617132; 2023.12.20]

Genetics

Developmental and epileptic encephalopathy 44 (DEE44) is caused by compound heterozygous mutation in the UBA5 gene on chromosome 3q22. [from MIM:617132; 2023.12.20]

Cellular phenotype and pathology
Molecular information

The UBA5 (Ubiquitin Like Modifier Activating Enzyme 5) gene encodes a member of the E1-like ubiquitin-activating enzyme family. This protein activates ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein, via the formation of a high-energy thioester bond. [provided by RefSeq, Feb 2016]

External links
Disease synonyms
DEE44
EIEE44
epileptic encephalopathy, early infantile 44
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

One to one (1 human to 1 Drosophila); UBA5 has one high-scoring Drosophila ortholog, Uba5.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Ubiquitin-like activating enzyme 5 (Uba5) encodes a member of the E1-like ubiquitin-activating enzyme family. It activates the protein encoded by Ufm1, and acts as a key factor in the ufmylation process. It is involved in ATP binding, catalytic activity, cofactor binding, metal ion binding, nucleotide binding and oxidoreductase activity. [Date last reviewed: 2019-09-26]
    Cellular component (GO)
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human UBA5 (1 Drosophila to 1 human).

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (3 groups)
      protein-protein
      Interacting group
      Assay
      References
      anti tag coimmunoprecipitation, peptide massfingerprinting
      anti tag coimmunoprecipitation, peptide massfingerprinting, anti bait coimmunoprecipitation, western blot
      Alleles Reported to Model Human Disease (Disease Ontology) (17 alleles)
      Models Based on Experimental Evidence ( 10 )
      Modifiers Based on Experimental Evidence ( 4 )
      Models Based on Experimental Evidence ( 3 )
      Modifiers Based on Experimental Evidence ( 1 )
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      loss of function allele
      CRISPR/Cas9
      amorphic allele
      References (5)